Results 221 to 230 of about 9,627,233 (299)

Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The prognosis of glioblastoma (GBM) remains highly unfavorable, largely due to high tumor heterogeneity and an immunosuppressive microenvironment. However, the functional role of PANoptosis in this context is poorly understood. Methods Patients were stratified via K‐means clustering. A risk score model was constructed using prognosis‐
Langfei Tian, Minghui Zhao, Yuanbo Hu, Kaiyue Wang, Haiguang Liu, Zetong Bai, Kebin Zheng   +6 more
wiley   +1 more source

PRIMARY INTRACRANIAL TUMORS: PROGNOSTIC FACTORS OF ORAL INTAKE SCALE OF PATIENTS PRE AND POST SURGICAL TREATMENT. [PDF]

Arq Gastroenterol
Braz LV, Furkim AM, Bilheri DFD, Aliano VA, Padilha FYOMM.   +4 more
europepmc   +1 more source

[Multiple primary malignant neoplasms].

Otolaryngologia polska = The Polish otolaryngology, 1974
R, Karwowski, B, Struzewski, W, Gajewski
openaire   +1 more source

CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct ...
Antonio Bruno, Matteo Conti, Ettore Dolcetti, Federica Azzolini, Angela Borrelli, Roberta Fantozzi, Mario Stampanoni Bassi, Giovanni Galifi, Giuseppe Maccarrone, Luca Montaguti, Marco Cervigni, Maddalena Dal Pozzo, Roberto Furlan, Annamaria Finardi, Girolama Alessandra Marfia, Marco Salvetti, Antonella Conte, Fabio Buttari, Diego Centonze, Luana Gilio   +19 more
wiley   +1 more source

Primary laryngeal paraganglioma with multisystem metastases: A case report. [PDF]

Medicine (Baltimore)
Xu X, Ma S, Zou Y.
europepmc   +1 more source

Clinical Impact of MGMT Promoter Methylation in IDH‐Mutant Gliomas: Influence of Threshold Selection and Clinical Confounding

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background The clinical relevance of MGMT promoter methylation in IDH‐mutant gliomas remains controversial in the era of molecular classification. We aimed to systematically evaluate its clinical relevance by integrating quantitative assessment, cutoff exploration, and adjustment for clinical confounding.
Haihui Jiang, Linxi Cao, Xiaodong Chen, Siqi Tong, Qinghui Zhu, Jun Yang, Song Lin, Yong Cui   +7 more
wiley   +1 more source

DNA methylation-based classification of hematolymphoid neoplasms. [PDF]

Blood Adv
Saksena A, Siewert C, Turakulov R, Singh O, Abdullaev Z, Zhou T, Karrs J, Alves De Castro JV, Riley D, Skarshaug S, Zgonc V, Sultanaeva L, Teng R, Xi L, Kreitman RJ, von Deimling A, Duran-Ferrer M, Martín-Subero JI, Campo E, Englert B, Richter J, Klapper W, Anagnostopoulos I, Rosenwald A, Wobser M, Fend F, Quintanilla-Martinez L, Ferrer G, Esteller M, Piris MA, Hummel M, Pittaluga S, Raffeld M, Jaffe ES, Capper D, Aldape K.   +35 more
europepmc   +1 more source

Early Clinical and Cerebrospinal Fluid Predictors of 1‐Year Recurrence in Autoimmune GFAP Astrocytopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong, Yuping Xiao, Yuhan Wu, Ziyuan Huang, Weishan Liang, Li Xiao, Yaqing Shu, Tingting Lu, Yanyu Chang, Wei Qiu, Yuge Wang   +10 more
wiley   +1 more source

Solitary Peritoneal Metastasis of AFP-Negative Hepatocellular Carcinoma in a 65-Year-Old Man with a History of Lung Adenocarcinoma: A Case Report. [PDF]

Am J Case Rep
Xie Z, Huang J, Fu K.
europepmc   +1 more source